IPN Ipsen S.A.

178.12USD162.40 EUR · EPA+0.06%Mkt Cap: 14.68B USDP/E: 26.28

Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally. It engages in the development of Soma…